These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7196633)

  • 21. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
    Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
    Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of histological and cytological studies of the prostate with special reference to oestrogene induced changes (author's transl)].
    Schubert GE; Ziegler H; Völter D
    Verh Dtsch Ges Pathol; 1973; 57():315-8. PubMed ID: 4142204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoma of the prostate in the elderly.
    Keegan GT; Coffield KS; Singh EO; Kroening PM
    Clin Geriatr Med; 1985 May; 1(2):359-71. PubMed ID: 3830370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The prognostic significance of cytologic differentiation grades of estrogen-treated prostata carcinoma. Progress control of 496 prostate carcinoma patients treated with estrogen for five years (author's transl)].
    Faul P; Schmiedt E; Kern R
    Urologe A; 1978 Nov; 17(6):377-81. PubMed ID: 726160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical significance of prostate cytology].
    Faul P
    Z Urol Nephrol; 1980; 73(7):549-54. PubMed ID: 6998182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability of cytological grading of prostatic carcinoma compared with histological grading.
    Yatani R; Shiraishi T; Soga T; Yabana T; Chigusa I; Shibata H
    Pathol Res Pract; 1985 Jul; 180(1):68-73. PubMed ID: 3898045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morphological factors in the prognosis of the treatment results in prostatic cancer].
    Murzaliev AD; Iiazaliev KT; Abdyldaev RA; Sizikov AI
    Urol Nefrol (Mosk); 1996; (1):22-5. PubMed ID: 8659037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.
    Yanagisawa N; Li R; Rowley D; Liu H; Kadmon D; Miles BJ; Wheeler TM; Ayala GE
    Hum Pathol; 2007 Nov; 38(11):1611-20. PubMed ID: 17868773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical experiences and advantages with aspiration biopsy of the prostate (author's transl)].
    Kaulen H; Davidts HH; Albrecht KF; Liebegott G
    Verh Dtsch Ges Pathol; 1973; 57():313-4. PubMed ID: 4142203
    [No Abstract]   [Full Text] [Related]  

  • 31. [Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer].
    Kameoka H; Katayose K; Kumakawa K; Shiraiwa Y; Uchida H; Takahashi Y; Yazaki J; Yamaguchi O
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):57-63. PubMed ID: 15675583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis].
    van der Kwast TH; Hoedemaeker RF; Schröder FH
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):972-6. PubMed ID: 15903037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal pattern in prostatic cancer. II. Correlation with primary response to endocrine treatment.
    Adlercreutz H; Rannikko S; Kairento AL; Karonen SL
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):634-40. PubMed ID: 7304086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies of clinical effects of ethinyl estradiol (a natural estrogen) on prostatic carcinoma (author's transl)].
    Kitajima N; Hosaka M; Fujii H; Mishimura R; Takai S
    Horumon To Rinsho; 1981 Feb; 29(2):223-8. PubMed ID: 7261442
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?
    Rubin MA; Mucci NR; Manley S; Sanda M; Cushenberry E; Strawderman M; Montie JE; Bassily NH
    J Urol; 2001 Jan; 165(1):114-8. PubMed ID: 11125378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The appearance of prostatic carcinomas in combined aspiration and coarse needle biopsies (author's transl)].
    Müller HA
    Verh Dtsch Ges Pathol; 1973; 57():329-33. PubMed ID: 4142208
    [No Abstract]   [Full Text] [Related]  

  • 37. Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer.
    Takayama H; Nonomura N; Nishimura K; Oka D; Shiba M; Nakai Y; Nakayama M; Tsujimura A; Aozasa K; Okuyama A
    BJU Int; 2009 Feb; 103(4):470-4. PubMed ID: 18778349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transrectal aspiration biopsy of the prostate].
    Göttinger H; Schmiedt E; Jocham D; Faul P
    Fortschr Med; 1980 Sep; 98(34):1273-8. PubMed ID: 7461532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M
    Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular markers and their prognostic impact in patients with advanced prostate cancer undergoing intermittent androgen suppression.
    Augustin H; Freibauer C; Bayer L; Lunglmayr G; Tschurlovich F; Kuber W; Pummer K
    Prostate Cancer Prostatic Dis; 2006; 9(3):279-83. PubMed ID: 16702984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.